Tapewire

Nasdaq · USD

CTMX

CytomX Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5124
SEC CIK
0001501989
Parsed reports
342

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202604
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 15, 2022 Filed Jun 17, 2022 20:04 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001567619-22-013069 · doc1.xml · derivative · entry 1

Ashworth Alan · CIK 0001886426 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-14

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:04 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001567619-22-013070 · doc1.xml · derivative · entry 1

Jones Elaine V · CIK 0001296907 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-14

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 16:05 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001567619-22-013071 · doc1.xml · derivative · entry 1

GLUCK FREDERICK W · CIK 0001184126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-14

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:06 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001567619-22-013073 · doc1.xml · derivative · entry 1

Meyers James R · CIK 0001387521 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-14

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:07 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001567619-22-013075 · doc1.xml · derivative · entry 1

Young Matthew P. · CIK 0001601583 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-14

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:07 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001567619-22-013074 · doc1.xml · derivative · entry 1

Mohindru Mani · CIK 0001664708 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-14

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:06 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $1.72 $0.00
Disclosure

SEC source: 0001567619-22-013072 · doc1.xml · derivative · entry 1

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-06-14

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
May 09, 2022 Filed May 11, 2022 20:51 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 24,189 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001567619-22-010091 · doc1.xml · derivative · entry 5

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,189 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
May 09, 2022 Filed May 11, 2022 20:51 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 66,742 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001567619-22-010091 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 66,742 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
May 09, 2022 Filed May 11, 2022 20:51 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 24,189 $0.95 $22,858.61
Disclosure

SEC source: 0001567619-22-010091 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,853

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 75,000 restricted stock units.

Read SEC document
May 09, 2022 Filed May 11, 2022 20:51 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 66,742 $0.95 $63,071.19
Disclosure

SEC source: 0001567619-22-010091 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 75,000 restricted stock units.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 16:52 UTC
ROWLAND LLOYD AGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 135,000 $0.00 Strike: $4.13 $0.00
Disclosure

SEC source: 0001567619-22-002524 · doc1.xml · derivative · entry 2

ROWLAND LLOYD A · CIK 0001236395 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,000

Underlying: Common Stock · 135,000 shares

Expires 2032-02-01

F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 16:52 UTC
ROWLAND LLOYD AGeneral Counsel
GrantCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-002524 · doc1.xml · nonDerivative · entry 1

ROWLAND LLOYD A · CIK 0001236395 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,291

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

F2 · balance_after: Includes 22,500 RSUs.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 21:53 UTC
Peterson Amy C.EVP, Chief Development Officer
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $4.13 $0.00
Disclosure

SEC source: 0001567619-22-002525 · doc1.xml · derivative · entry 2

Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-02-01

F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 21:53 UTC
Peterson Amy C.EVP, Chief Development Officer
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-002525 · doc1.xml · nonDerivative · entry 1

Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,421

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

F2 · balance_after: Includes 40,000 RSUs.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 21:51 UTC
HANNAH ALISON L.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 135,000 $0.00 Strike: $4.13 $0.00
Disclosure

SEC source: 0001567619-22-002523 · doc1.xml · derivative · entry 2

HANNAH ALISON L. · CIK 0001645600 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,000

Underlying: Common Stock · 135,000 shares

Expires 2032-02-01

F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 21:51 UTC
HANNAH ALISON L.Chief Medical Officer
GrantCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-002523 · doc1.xml · nonDerivative · entry 1

HANNAH ALISON L. · CIK 0001645600 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,500

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

F2 · balance_after: Includes 22,500 RSUs.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 21:50 UTC
Campoy CarlosChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 135,000 $0.00 Strike: $4.13 $0.00
Disclosure

SEC source: 0001567619-22-002522 · doc1.xml · derivative · entry 2

Campoy Carlos · CIK 0001761518 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,000

Underlying: Common Stock · 135,000 shares

Expires 2032-02-01

F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 21:50 UTC
Campoy CarlosChief Financial Officer
GrantCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-002522 · doc1.xml · nonDerivative · entry 1

Campoy Carlos · CIK 0001761518 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,921

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

F2 · balance_after: Includes 22,500 RSUs.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 21:49 UTC
McCarthy Sean A.Director · President and CEO
GrantStock Option (Right to Buy) · Derivative 450,000 $0.00 Strike: $4.13 $0.00
Disclosure

SEC source: 0001567619-22-002521 · doc1.xml · derivative · entry 3

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2032-02-01

F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 21:49 UTC
McCarthy Sean A.Director · President and CEO
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-22-002521 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,922

F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

F2 · balance_after: Includes 75,000 RSUs.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 16:29 UTC
ROWLAND LLOYD AGeneral Counsel
GrantPerformance Stock Units (PSUs) · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-018719 · doc1.xml · derivative · entry 2

ROWLAND LLOYD A · CIK 0001236395 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 16:29 UTC
ROWLAND LLOYD AGeneral Counsel
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $5.34 $0.00
Disclosure

SEC source: 0001567619-21-018719 · doc1.xml · derivative · entry 1

ROWLAND LLOYD A · CIK 0001236395 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-10-23

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 20:30 UTC
McCarthy Sean A.Director · President and CEO
GrantPerformance Stock Units (PSUs) · Derivative 80,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-018720 · doc1.xml · derivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 20:30 UTC
McCarthy Sean A.Director · President and CEO
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $5.34 $0.00
Disclosure

SEC source: 0001567619-21-018720 · doc1.xml · derivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-10-23

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 20:26 UTC
Peterson Amy C.EVP, Chief Development Officer
GrantPerformance Stock Units (PSUs) · Derivative 40,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-018718 · doc1.xml · derivative · entry 2

Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 20:26 UTC
Peterson Amy C.EVP, Chief Development Officer
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $5.34 $0.00
Disclosure

SEC source: 0001567619-21-018718 · doc1.xml · derivative · entry 1

Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-10-23

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 20:25 UTC
Campoy CarlosChief Financial Officer
GrantPerformance Stock Units (PSUs) · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-018717 · doc1.xml · derivative · entry 2

Campoy Carlos · CIK 0001761518 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 20:25 UTC
Campoy CarlosChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $5.34 $0.00
Disclosure

SEC source: 0001567619-21-018717 · doc1.xml · derivative · entry 1

Campoy Carlos · CIK 0001761518 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-10-23

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 20:24 UTC
HANNAH ALISON L.Chief Medical Officer
GrantPerformance Stock Units (PSUs) · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-21-018716 · doc1.xml · derivative · entry 2

HANNAH ALISON L. · CIK 0001645600 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.exercise_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

F2 · derivative.expiration_date: Each Performance Stock Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date.

Read SEC document
October 24, 2021 Filed Oct 26, 2021 20:24 UTC
HANNAH ALISON L.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $5.34 $0.00
Disclosure

SEC source: 0001567619-21-018716 · doc1.xml · derivative · entry 1

HANNAH ALISON L. · CIK 0001645600 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-10-23

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.

Read SEC document
September 29, 2021 Filed Oct 7, 2021 21:12 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $4.93 $0.00
Disclosure

SEC source: 0001567619-21-018045 · doc1.xml · derivative · entry 1

Ashworth Alan · CIK 0001886426 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-09-28

F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 29, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Read SEC document
August 11, 2021 Filed Aug 13, 2021 21:22 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 92,113 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001567619-21-015554 · doc1.xml · derivative · entry 3

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 92,113 shares

Expires 2021-09-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Exercise of September 2021 expiring stock options with cash.

F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
August 11, 2021 Filed Aug 13, 2021 21:22 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 92,113 $1.13 $104,446.93
Disclosure

SEC source: 0001567619-21-015554 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,922

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Amount of securities held has been adjusted to reflect the transfer of 40 shares previously owned directly to Sean A. McCarthy 2018 Trust.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 22:44 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $7.13 $0.00
Disclosure

SEC source: 0001567619-21-012367 · doc1.xml · derivative · entry 1

Jones Elaine V · CIK 0001296907 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 18:46 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $7.13 $0.00
Disclosure

SEC source: 0001567619-21-012369 · doc1.xml · derivative · entry 1

SCARLETT JOHN A · CIK 0001270928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 18:43 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $7.13 $0.00
Disclosure

SEC source: 0001567619-21-012365 · doc1.xml · derivative · entry 1

GLUCK FREDERICK W · CIK 0001184126 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 22:45 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $7.13 $0.00
Disclosure

SEC source: 0001567619-21-012368 · doc1.xml · derivative · entry 1

Meyers James R · CIK 0001387521 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 22:48 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $7.13 $0.00
Disclosure

SEC source: 0001567619-21-012372 · doc1.xml · derivative · entry 1

Mohindru Mani · CIK 0001664708 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 22:47 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $7.13 $0.00
Disclosure

SEC source: 0001567619-21-012371 · doc1.xml · derivative · entry 1

Young Matthew P. · CIK 0001601583 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 16, 2021 Filed Jun 17, 2021 22:43 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $7.13 $0.00
Disclosure

SEC source: 0001567619-21-012364 · doc1.xml · derivative · entry 1

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-06-15

F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 19:51 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 100,000 $7.04 $704,470.00
Disclosure

SEC source: 0001567619-21-012419 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 93,118

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades in prices ranging from $6.88 to $7.135, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.

Read SEC document
June 14, 2021 Filed Jun 17, 2021 01:49 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 10 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001567619-21-012252 · doc1.xml · derivative · entry 5

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,742

Underlying: Common Stock · 10 shares

Expires 2023-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
June 14, 2021 Filed Jun 17, 2021 01:49 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 30 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001567619-21-012252 · doc1.xml · derivative · entry 4

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,113

Underlying: Common Stock · 30 shares

Expires 2021-09-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
June 14, 2021 Filed Jun 17, 2021 01:49 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 10 $0.95 $9.45
Disclosure

SEC source: 0001567619-21-012252 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,849

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 14, 2021 Filed Jun 17, 2021 01:49 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionCommon Stock 30 $1.13 $34.02
Disclosure

SEC source: 0001567619-21-012252 · doc1.xml · nonDerivative · entry 1

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 31, 2021 Filed Jun 8, 2021 17:08 UTC
Campoy CarlosChief Financial Officer
GrantCommon Stock 3,320 $6.09 $20,205.52
Disclosure

SEC source: 0001567619-21-011807 · doc1.xml · nonDerivative · entry 1

Campoy Carlos · CIK 0001761518 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,421

F1 · kind: 3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
May 31, 2021 Filed Jun 8, 2021 17:07 UTC
Peterson Amy C.EVP, Chief Development Officer
GrantCommon Stock 3,320 $6.09 $20,205.52
Disclosure

SEC source: 0001567619-21-011806 · doc1.xml · nonDerivative · entry 1

Peterson Amy C. · CIK 0001682735 · EVP, Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,421

F1 · kind: 3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
March 31, 2021 Filed Apr 2, 2021 21:37 UTC
McCarthy Sean A.Director · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $1.13 $0.00
Disclosure

SEC source: 0001567619-21-007541 · doc1.xml · derivative · entry 3

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,143

Underlying: Common Stock · 100,000 shares

Expires 2021-09-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 21:37 UTC
McCarthy Sean A.Director · President and CEO
SaleCommon Stock 100,000 $7.49 $749,470.00
Disclosure

SEC source: 0001567619-21-007541 · doc1.xml · nonDerivative · entry 2

McCarthy Sean A. · CIK 0001654058 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,894

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades in prices ranging from $7.35 to $7.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.